Steady on KC. I’m not seeing a $1 party any time soon.
Going back to the Van Leeuwenhoeck report (link provided below), it’s final verdict after running the numbers was that POH’s fair sp value was approx. 8 - 9c. At the time it was written, the sp was 0.007.
The Van Leeuwenhoeck valuation was based only on POH’s opioid patch assets. If the figures were reworked, based on an assumption of $350 million peak sales for the oxymorphone patch, you would probably find that the 8-9c estimate would only increase by a couple of cents.
Personally, I think that would still undervalue the company, as the van Leeuwenhoeck estimate attributes no value to any of the other POH pipeline products, such as the TPM injectable pipeline.
BUT, as GC says, it’s all worth diddley- squat unless POH lands a deal.
http://www.phosphagenics.com/wp-con...search-Report-on-Phosphagenics-9-Feb-2016.pdf
- Forums
- ASX - By Stock
- AVE
- New Investor Fact Sheet
New Investor Fact Sheet, page-21
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $500 | 250K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 45759211 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 45964683 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
33 | 45459211 | 0.002 |
17 | 23466742 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 45964683 | 26 |
0.004 | 34898435 | 19 |
0.005 | 15900219 | 9 |
0.006 | 17380067 | 10 |
0.007 | 5572471 | 5 |
Last trade - 13.36pm 30/09/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |